CLYM FY 2025 Earnings — Climb Bio, Inc. Revenue & Financial Results | Market Cap Arena

CLYMClimb Bio, Inc.

$522M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$97,000

Operating Income

-$68M

Net Income

-$60M

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$55M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$168M

Total Liabilities

$7M

Stockholders' Equity

$160M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$97,000	$0	—
Operating Income	-$68M	-$82M	+17.2%
Net Income	-$60M	-$74M	+19.0%